Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Splanchnic Nerve Blockade in Chronic Heart Failure
NCT03453151Phase 2Completed
- Sponsor
- Duke University
- Start
- May 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine, bupivacaine in heart failure (HF), sponsored by Duke University. Started May 2018; status: completed.
02
Drugs
lidocainebupivacaine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03453151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03453151.